American Journal of Transplantation · 2017 · 30 citations · 8 references
MedicineHematologyPediatricsHepatologyIron Metabolism DisordersStem Cell TransplantationAnemiaHeme MetabolismInborn Errors Of MetabolismLiver DiseaseLiver TransplantationPediatric Liver DiseaseErythropoiesis DisordersFerrochelatase FunctionHeme Biosynthesis DisordersHeme Iron MetabolismHeme Oxygenase PathwayLiver Disease ComplicationsMutationProtoporphyrinogen Accumulation
Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues. Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients. Although the major symptom of this disorder is photosensitivity, rarely, it can cause progressive liver disease requiring liver transplantation (LT). However, LT is not curative and only bone marrow transplantation (BMT) can correct the underlying enzymatic defect. Because liver disease results from accumulation of protoporphyrin in the liver, LT without hematopoietic stem cell transplantation leaves the new liver at risk for similar EPP-related damage. A handful of pediatric patients undergoing sequential LT and stem cell transplantation have been described in the literature; however, to date none has been described in detail in adults. We report a case of an adult male with EPP and liver failure who successfully underwent a sequential liver and hematopoietic stem cell transplantation (HSCT). Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues. Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients. Although the major symptom of this disorder is photosensitivity, rarely, it can cause progressive liver disease requiring liver transplantation (LT). However, LT is not curative and only bone marrow transplantation (BMT) can correct the underlying enzymatic defect. Because liver disease results from accumulation of protoporphyrin in the liver, LT without hematopoietic stem cell transplantation leaves the new liver at risk for similar EPP-related damage. A handful of pediatric patients undergoing sequential LT and stem cell transplantation have been described in the literature; however, to date none has been described in detail in adults. We report a case of an adult male with EPP and liver failure who successfully underwent a sequential liver and hematopoietic stem cell transplantation (HSCT).
8
Liver transplantation for erythropoietic protoporphyria liver disease
Brendan M. McGuire, Herbert L. Bonkovsky, Robert L. Carithers et al. · Liver Transplantation · 2005 · 162 citations · Full text
Medicine, Hematology, Surgery +17
Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria
S. Alexander Holme, Mark Worwood, A. Anstey et al. · Blood · 2007 · 102 citations · Full text
Medicine, Biology, Hematology +14
Sequential Liver and Bone Marrow Transplantation for Treatment of Erythropoietic Protoporphyria
Elizabeth B. Rand, Nancy Bunin, W. Cochran et al. · PEDIATRICS · 2006 · 95 citations
Medicine, Biochemistry, Hematology +15
Liver transplantation for erythropoietic protoporphyria in Europe
Staffan Wåhlin, Per Stål, René Adam et al. · Liver Transplantation · 2011 · 80 citations · Full text
Medicine, Surgery, Toxicology +12